Control group (n = 88) | Lidocaine group (n = 88) | p | |
---|---|---|---|
Sex, n (%) | |||
Male | 39 (44.3) | 37 (42.1) | 0.879 |
Age (years), mean (SD) | 66.6 (7.6) | 65.8 (8.9) | 0.501 |
Systemic underlying disease, n (%) | |||
Hypertension | 41 (46.6) | 48 (54.6) | 0.366 |
Dyslipidemia | 35 (39.8) | 29 (33.0) | 0.433 |
Diabetes mellitus | 23 (26.1) | 21 (23.9) | 0.862 |
Chronic kidney disease | 6 (6.8) | 8 (9.1) | 0.782 |
Underlying ocular disease, n (%) | |||
Glaucoma | 9 (10.2) | 10 (11.4) | > 0.999 |
NPDR | 0 (0) | 2 (2.3) | 0.497 |
Optic neuropathy | 1 (1.1) | 0 (0) | > 0.999 |
Cataract grade, n (%) | 0.267 | ||
NUC1 | 28 (31.8) | 19 (21.6) | |
NUC2 | 38 (43.2) | 36 (40.9) | |
NUC3 | 4 (4.6) | 6 (6.8) | |
Mature cataract | 18 (20.5) | 27 (30.7) | |
Second eye operation*, n (%) | 26 (29.6) | 26 (29.6) | > 0.999 |
Unplanned additional surgery†, n (%) | 1 (1.1) | 2 (2.3) | 0.497 |
Corneal suturing‡, n (%) | 15 (17.1) | 11 (12.5) | 0.525 |
Operative time (min), mean (SD) | 17.8(4.3) | 17.8(5.7) | 0.905 |
Complications, n (%) | |||
Complications related to the anesthetic technique: Subconjunctival hemorrhage | 6 (6.8) | 27 (30.7) | < 0.001 |
Surgical complications | 0.371 | ||
- Posterior capsular rupture | 0 (0) | 2 (2.3) | |
- Iris trauma | 1 (1.1) | 0 (0) | |
- Subconjunctival hemorrhage | 0 (0) | 1 (1.1) |